Application of novel CRISPR tools in brain therapy

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) system has revolutionized genome editing.
• Expanding CRISPR applications now include epigenetic editing and gene expression control.

Purpose of the Study:

• To provide a comprehensive overview of recent advancements in CRISPR gene editing tools.
• To examine the applications of CRISPR technology in treating brain diseases.
• To explore the synergy between CRISPR and Chimeric Antigen Receptor T-cell (CAR-T) technology.

Main Methods:

• Review of CRISPR-associated (Cas) proteins and their functions.
• Exploration of epigenetic editing, base editing, and prime editing techniques.
• Analysis of CRISPR applications in neurological disease modeling, gene screening, and therapeutic editing.

Main Results:

• CRISPR technology has evolved beyond basic genome modification to encompass epigenetic and gene expression control.
• Significant progress has been made in applying CRISPR tools to various brain disorders, including neurodegenerative diseases, genetic disorders, epilepsy, and brain tumors.
• The integration of CRISPR with CAR-T technology shows promise for novel therapeutic strategies.

Conclusions:

• CRISPR gene editing tools offer diverse and expanding applications, particularly in brain disease therapeutics.
• Further research and development are needed to overcome technical challenges for widespread clinical implementation.
• The combination of CRISPR and CAR-T represents a promising frontier in disease treatment.